Single center real life study Blinatumomab for the treatment of adult relapsed/refractory philadelphia chromosome-negative B-cell acute lymphoblastic leukemia
Latest Information Update: 06 Aug 2021
At a glance
- Drugs Blinatumomab (Primary)
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 06 Aug 2021 New trial record
- 17 Jun 2021 Results presented at the 26th Congress of the European Haematology Association